HY-10262 is primarily utilized in the field of medical research, particularly in the study of cancer and inflammatory diseases. It functions as a selective inhibitor, targeting specific pathways involved in cell proliferation and inflammation. Researchers employ this compound to investigate its potential in disrupting tumor growth and reducing inflammatory responses in various experimental models. Its application extends to preclinical studies, where it aids in understanding the mechanisms of disease progression and evaluating the efficacy of therapeutic interventions. Additionally, HY-10262 is explored for its role in enhancing the effectiveness of existing treatments, offering a promising avenue for developing novel therapeutic strategies.